Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Autoantibodies Against LINE-1 p40 May Be More Common in Patients with Active SLE

Vanessa Caceres  |  March 17, 2021

Researchers found nearly all systemic lupus erythematosus (SLE) patients have autoantibodies against long interspersed nuclear elements (LINE-1) p40. These findings suggest LINE-1 may be involved in the pathogenesis of SLE.

New Clinical Trials for Ustekinumab & Denosumab Biosimilars Begin Recruitment

Michele B. Kaufman, PharmD, BCGP  |  March 17, 2021

Clinical trials of biosimilar treatments, including a phase 1 study of SB17, which is biosimilar to ustekinumab, and two phase 3 studies investigating of SB16, which is biosimilar to denosumab, are currently recruiting.

High-Intensity Strength Training May Not Improve OA Knee Pain

Lara C. Pullen, PhD  |  March 17, 2021

High-intensity strength training may be no more beneficial than low-intensity strength training at improving pain and joint compression in patients with knee osteoarthritis, according to a recent study.

Coronavirus Vaccination Assistance

Philip Seo, MD, MHS  |  March 16, 2021

Each state has different requirements for residents to obtain a coronavirus vaccination, with some allowing preregistration and others coordinating vaccinations via employers or the local health department. Below, we list some online resources created to help people determine whether they qualify for coronavirus vaccination and where they should go to schedule an appointment, broken down…

German Society Updates Rheumatic Diseases Guidelines in Light of COVID-19 Pandemic

Marilynn Larkin  |  March 10, 2021

NEW YORK (Reuters Health)—The German Society for Rheumatology (DGRh) has updated its guidelines to reflect the recent impact of the pandemic, noting among its key changes that immunosuppressive medications should not be changed solely for fear of SARS-CoV-2 infection.1 The update is based on evidence from scientific data from registries, cross-sectional studies, case reports and…

What’s in the New COVID-19 Relief Package?

From the College  |  March 10, 2021

The U.S. House of Representatives passed the American Rescue Plan Act of 2021 (H.R. 1319) on March 10, 2021, after Senate passage on March 6. President Biden signed the bill into law on March 11. Following is the ACR’s summary of the most impactful provisions of this third COVID-19 relief package. Fighting COVID-19 $160 billion…

CDC Says Fully Vaccinated People Can Gather Unmasked with Others Indoors

Reuters Staff  |  March 10, 2021

NEW YORK (Reuters)—Individuals fully inoculated against COVID-19 can meet in small groups with other vaccinated people without wearing masks, but should keep wearing them outside the home, the U.S. Centers for Disease Control and Prevention (CDC) said on March 8. CDC Director Rochelle Walensky, MD, MPH, said during a briefing that the agency’s new guidance…

State-of-the-Art Clinical Symposium Premeeting Courses Feature Billing, Coding & Insurance Opportunities

From the College  |  March 8, 2021

Courses before the 2021 State-of-the-Art Clinical Symposium will focus heavily on what’s new in practice, including mastering evaluation and management changes and access to treatments in rheumatology. Early bird registration ends March 31.

ACR, Coalition Ask Congress to Fund Pediatric Subspecialty Loan Repayment Program

From the College  |  March 8, 2021

The ACR has joined with a coalition of organizations dedicated to improving the health and wellbeing of children and adolescents to request $50 million to fund the Pediatric Subspecialty Loan Repayment Program.

Health Canada Approves CT-P13 SC for RA; Plus Tofacitinib May Increase Cardiac & Cancer Risks

Michele B. Kaufman, PharmD, BCGP  |  March 5, 2021

In Canada, a subcutaneous formulation of CT-P13, which is biosimilar to infliximab, was approved to treat rheumatoid arthritis.

  • « Previous Page
  • 1
  • …
  • 74
  • 75
  • 76
  • 77
  • 78
  • …
  • 325
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences